CollPlant Biotechnologies (CLGN) Assets (2017 - 2026)

CollPlant Biotechnologies has reported Assets for 10 years, with the latest figure at $9.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 53264.71% year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2026 stood at $9.2 million (up 53264.71% YoY), and the FY2025 full-year result was $10.8 million, down 42.36% from the prior year.
• Assets for Q1 2026 stood at $9.2 million, down from $10.8 million in the prior quarter.
• The five-year high for Assets was $48.7 million in Q1 2022, with the low at $17208.0 in Q1 2025.
• Historically, Assets has averaged $22.3 million across 5 years, with a median of $18.7 million in 2024.
• Annual changes were most pronounced in 2022 — Assets soared 85931.36% — and 2024, when it plunged 99.92%.
• CollPlant Biotechnologies' Assets stood at $37.8 million in 2022, then fell by 9.64% to $34.1 million in 2023, then plunged by 45.17% to $18.7 million in 2024, then slumped by 42.36% to $10.8 million in 2025, then decreased by 14.85% to $9.2 million in 2026.
• The last three Assets figures came in at $9.2 million (Q1 2026), $10.8 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.